N. Alessi

Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity

G. Gerken, T. Marafioti, A. Spadaro, 1995, Hepatology.

Ten year follow-up of patients with chronic hepatitis C treated with interferon.

P. Consolo, A. Spadaro, M. Freni, 1999, Hepato-gastroenterology.

Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma.

A. Alibrandi, G. D’Arrigo, S. Campo, 2006, World journal of gastroenterology.

HCV infection, hepatic HLA display and composition of the mononuclear cell inflammatory infiltrate in chronic alcoholic liver disease

G. Gaeta, A. Spadaro, M. Freni, 1991, European journal of clinical investigation.

Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C.

A. Spadaro, M. Freni, O. Ferraù, 2003, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

Soluble CD30 serum levels before and after treatment with α-interferon in patients with chronic hepatitis C

C. Luigiano, A. Spadaro, M. Freni, 2005, Clinical chemistry and laboratory medicine.

Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: effect of treatment with recombinant alpha interferon.

T. Marafioti, A. Spadaro, M. Freni, 1997, Hepato-gastroenterology.

Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity

G. Gerken, T. Marafioti, A. Spadaro, 1995, Hepatology.